Closed
SectorHealthcare
454.39 5.03
24h
Min
431.5
Max
456.77
Income | 31M -42M |
---|---|
Sales | 76M 213M |
EPS | -1.9 |
Profit margin | -19.869 |
Employees | 528 |
EBITDA | 31M -39M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +8.23% upside |
Next Earnings | 30 paź 2025 |
---|
Market Cap | 2.8B 9.8B |
---|---|
Previous open | 449.36 |
Previous close | 454.39 |
By Acuity
40%
60%
147 / 371 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 468.5 USD 8.23%
High 567 USD
Low 266 USD
Based on 14 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$